West Pharmaceutical Services (WST) Equity Ratio (2009 - 2026)

West Pharmaceutical Services has disclosed Equity Ratio across 18 years of filings, most recently posting 0.73 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.73, down 1.88% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.73 (down 1.88% YoY), and the FY2025 annual result was 0.74, up 1.03% from the prior year.
• Equity Ratio came in at 0.73 for Q1 2026 at West Pharmaceutical Services, down from 0.74 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.76 in Q3 2023 to a low of 0.71 in Q1 2022.
• The 5-year median for Equity Ratio is 0.74 (2025), against an average of 0.74.
• Across the five-year window, Equity Ratio grew 6.3% in 2022 and declined 2.14% in 2024, its largest moves.
• West Pharmaceutical Services' Equity Ratio stood at 0.74 in 2022, then rose by 1.34% to 0.75 in 2023, then declined by 2.14% to 0.74 in 2024, then grew by 1.03% to 0.74 in 2025, then fell by 2.17% to 0.73 in 2026.
• The last three Equity Ratio figures came in at 0.73 (Q1 2026), 0.74 (Q4 2025), and 0.74 (Q3 2025), per Business Quant data.